Sandesh Seth
Chief Executive Officer presso ACTINIUM PHARMACEUTICALS, INC.
Patrimonio netto: 42 133 $ in data 31/03/2024
Profilo
Sandesh Seth is currently the Chairman & Chief Executive Officer at Actinium Pharmaceuticals, Inc. He is also a Managing Partner at Jamess Capital Group LLC.
Previously, he served as the Chairman of Relmada Therapeutics, Inc. from 2015 to 2017.
He has also held positions as a Director at Actinium Pharmaceuticals, Inc., Cactus Ventures, Inc., Camp Nine, Inc., and Relmada Therapeutics, Inc. Additionally, he was the Head-Healthcare Investment Banking at Laidlaw & Co. (UK) Ltd.
Mr. Seth holds an MBA from New York University and an undergraduate degree from the University of Mumbai.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 28/12/2023 | 5 381 ( 0.02% ) | 42 133 $ | 31/03/2024 |
Posizioni attive di Sandesh Seth
| Società | Posizione | Inizio |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Chief Executive Officer | 09/06/2017 |
| Jamess Capital Group LLC | Corporate Officer/Principal | - |
Precedenti posizioni note di Sandesh Seth
| Società | Posizione | Fine |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Chairman | 06/06/2017 |
Laidlaw & Co. (UK) Ltd.
 Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Part of Laidlaw Holdings Ltd., Laidlaw & Co. (UK) Ltd. is a British company that provides investment advice. The private company is based in London, UK. The company was founded in 1842. Matthew D. Eitner has been the CEO of the company since 2010. | Corporate Officer/Principal | 01/07/2015 |
Actinium Pharmaceuticals, Inc. /Old/
 Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Actinium Pharmaceuticals, Inc. provides development and commercialization of alpha particle immunotherapeutics services. It conducts research based on a patient position for the utilization of actinium-225 and bismuth-213. The company has offices in Oak Ridge, TN and Alexandria, VA. Actinium Pharmaceuticals was founded in 1993 and is headquartered in Florham Park, NJ. | Director/Board Member | 18/04/2013 |
Cactus Ventures, Inc.
 Cactus Ventures, Inc. Financial ConglomeratesFinance Cactus Ventures, Inc. operates as a blank check company. Cactus Ventures intends to locate and negotiate with a business entity for the merger of that target company into the company. The company was founded on October 6, 1997 and is headquartered in Carson City, NV. | Director/Board Member | 18/04/2013 |
Camp Nine, Inc.
 Camp Nine, Inc. Pharmaceuticals: GenericHealth Technology Camp Nine, Inc. operates as a clinical stage biopharmaceutical company. The company through its subsidiary Relmada Therapeutics, Inc. focused on developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of pain. Camp Nine was founded on May 31, 2012 and is headquartered in New York, NY. | Director/Board Member | - |
Formazione di Sandesh Seth
| New York University | Masters Business Admin |
| University of Mumbai | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| RELMADA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Actinium Pharmaceuticals, Inc. provides development and commercialization of alpha particle immunotherapeutics services. It conducts research based on a patient position for the utilization of actinium-225 and bismuth-213. The company has offices in Oak Ridge, TN and Alexandria, VA. Actinium Pharmaceuticals was founded in 1993 and is headquartered in Florham Park, NJ. | Commercial Services |
Cactus Ventures, Inc.
Cactus Ventures, Inc. Financial ConglomeratesFinance Cactus Ventures, Inc. operates as a blank check company. Cactus Ventures intends to locate and negotiate with a business entity for the merger of that target company into the company. The company was founded on October 6, 1997 and is headquartered in Carson City, NV. | Finance |
Camp Nine, Inc.
Camp Nine, Inc. Pharmaceuticals: GenericHealth Technology Camp Nine, Inc. operates as a clinical stage biopharmaceutical company. The company through its subsidiary Relmada Therapeutics, Inc. focused on developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of pain. Camp Nine was founded on May 31, 2012 and is headquartered in New York, NY. | Health Technology |
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Part of Laidlaw Holdings Ltd., Laidlaw & Co. (UK) Ltd. is a British company that provides investment advice. The private company is based in London, UK. The company was founded in 1842. Matthew D. Eitner has been the CEO of the company since 2010. | Finance |
Relmada Therapeutics, Inc. /Old/
 Relmada Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Relmada Therapeutics, Inc. is a holding company, which engages in the development of pharmaceutical drugs for the treatment of acute and chronic pains. It focuses in the developing of chronic pain due to cancer, musculoskeletal disorders, and peripheral neuropathy. The company was founded in 2000 and is headquartered in Blue Bell, PA. | Health Technology |
| Jamess Capital Group LLC |
- Borsa valori
- Insiders
- Sandesh Seth
